Respiratory Syncytial Virus in Veneto Region: Analysis of Hospital Discharge Records from 2007 to 2021.
Veneto region
hospitalizations
infants
respiratory syncytial virus
trends
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
04 03 2023
04 03 2023
Historique:
received:
27
12
2022
revised:
01
03
2023
accepted:
02
03
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
15
3
2023
Statut:
epublish
Résumé
Respiratory Syncytial Virus (RSV) is a known cause of acute lower respiratory infections in infants and young children. The present study aims to analyze the temporal trends and characteristics of hospitalization related to RSV in the Veneto region (Italy) in the period between 2007 and 2021. The analysis is performed on all the hospital discharge records (HDRs) of public and accredited private hospitals corresponding to hospitalizations occurring in the Veneto region (Italy). HDRs are considered if they included at least one of the following ICD9-CM codes: 079.6-Respiratory Syncytial Virus (RSV); 466.11-acute bronchiolitis due to RSV; and 480.1-pneumonia due to RSV. Total annual cases, sex, and age-specific rates and trends are evaluated. Overall, an increasing trend in the number of hospitalizations due to RSV was observed between 2007 and 2019, with a slight drop in RSV seasons 2013-2014 and 2014-2015. From March 2020 to September 2021, almost no hospitalization was registered, but in the last quarter of 2021, the number of hospitalizations reached its highest value in the series. Our data confirm the preponderance of RSV hospitalizations in infants and young children, the seasonality of RSV hospitalizations, and acute bronchiolitis as the most frequent diagnosis. Interestingly, the data also show the existence of a significant burden of disease and a non-negligible number of deaths also in older adults. The present study confirms RSV is associated with high rates of hospitalization in infants and sheds light on the burden in the 70+ age group in which a considerable number of deaths was observed, as well as the parallelism with other countries, which is consistent with a wide underdiagnoses issue.
Identifiants
pubmed: 36901576
pii: ijerph20054565
doi: 10.3390/ijerph20054565
pmc: PMC10002215
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Vaccines (Basel). 2021 Nov 16;9(11):
pubmed: 34835265
Children (Basel). 2022 Dec 17;9(12):
pubmed: 36553433
J Glob Health. 2015 Dec;5(2):020416
pubmed: 26682048
Int J Environ Res Public Health. 2022 Nov 09;19(22):
pubmed: 36429399
Lancet. 2017 Sep 2;390(10098):946-958
pubmed: 28689664
PLoS One. 2017 Aug 10;12(8):e0182321
pubmed: 28797053
PLoS One. 2016 Apr 06;11(4):e0152208
pubmed: 27050095
Ther Adv Infect Dis. 2019 Jul 29;6:2049936119865798
pubmed: 31384456
J Paediatr Child Health. 2018 Dec;54(12):1321-1328
pubmed: 29873433
Ital J Pediatr. 2018 May 4;44(1):50
pubmed: 29728106
Vaccines (Basel). 2020 Jan 04;8(1):
pubmed: 31947976
BMC Infect Dis. 2015 Oct 23;15:443
pubmed: 26497750
J Infect Dis. 2012 Jul 1;206(1):56-62
pubmed: 22529314
Eur Respir J. 2021 Oct 1;58(3):
pubmed: 33888523
J Infect Dis. 2022 Aug 15;226(Suppl 2):S154-S163
pubmed: 35968878
J Infect Dis. 2020 Oct 7;222(Suppl 7):S599-S605
pubmed: 32815542
Stat Med. 2000 Feb 15;19(3):335-51
pubmed: 10649300
Pediatrics. 2022 Feb 1;149(2):
pubmed: 35083489
J Infect Dis. 2020 Oct 7;222(Suppl 7):S577-S583
pubmed: 30880339